Healthcare -
Medical - Instruments & Supplies - NYSE - US
$ 68.7
2.23 %
$ 3.45 B
Market Cap
27.05
P/E
Price Target
Average
57.57%
Revenue Forecast
Estimate
7.07%
EBIT
Estimate
3.31%
Net Income
Estimate
41.83%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Haemonetics Corporation
Wall Street analysts predict an average 1-year price target for HAE of $108 , with forecasts ranging from
a
low of
$85 to a high of $120 .
HAE Lowest Price Target
Wall Street Target
85 USD
23.73%
HAE Average Price Target
Wall Street Target
108 USD
57.57%
HAE Highest Price Target
Wall Street Target
120 USD
74.67%
REVENUE FORECAST
Revenue Forecast Chart HAE
EBIT FORECAST
EBIT Forecast Chart HAE
NET INCOME FORECAST
Net Income Chart HAE